Literature DB >> 4062902

Physicochemical characterization of human S-protein and its function in the blood coagulation system.

K T Preissner, R Wassmuth, G Müller-Berghaus.   

Abstract

S-protein, the main inhibitor of the assembly of the membrane attack complex of complement, was isolated from human plasma by a simple purification procedure, which includes barium citrate adsorption, ammonium sulphate precipitation, chromatography on DEAE-Sephacel and Blue Sepharose and gel filtration on Sephacryl S-200. The homogeneous protein (sedimentation coefficient 4.6 S) was obtained in approx. 5% yield relative to its concentration in plasma, which was found to be 0.3-0.5 mg/ml. The final product did not cross-react with antisera against complement proteins or other proteinase inhibitors of human plasma. On polyacrylamide-gel electrophoresis in the presence of sodium dodecyl sulphate, S-protein migrated as a single-chain band with an apparent Mr of 74000 under non-reducing conditions and as a doublet of Mr 78000 and 65000 upon reduction. In plasma or serum S-protein also existed in two forms of corresponding Mr values, as was evidenced by an immunoblot enzyme-linked immunosorbent assay technique. S-protein was found to be an acidic glycoprotein with 10% (W/W) carbohydrate content and several isoelectric points in the range pH 4.75-5.25, and it contained one free thiol group per molecule of protein. The functional properties of S-protein in the complement system were demonstrated by its ability to inhibit complement-dependent cell lysis in a concentration-dependent manner (Ki 0.6 microM) and by its incorporation into the nascent SC5b-7 complex. A new function for S-protein could be revealed in the blood coagulation system. The slow progressive inhibition of thrombin by antithrombin III was not affected by S-protein, whereas the purified protein interfered with the fast inactivation of thrombin clotting as well as amidolytic activity by antithrombin III-heparin complex. The acceleration of this inhibition reaction by heparin was counteracted by S-protein, indicating the ability of S-protein to neutralize heparin activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4062902      PMCID: PMC1152752          DOI: 10.1042/bj2310349

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Proteolytic transformation of SC5b-9 into an amphiphilic macromolecule resembling the C5b-9 membrane attack complex of complement.

Authors:  S Bhakdi; B Bhakdi-Lehnen; J Tranum-Jensen
Journal:  Immunology       Date:  1979-08       Impact factor: 7.397

2.  MOLECULAR EXCLUSION AND RESTRICTED DIFFUSION PROCESSES IN MOLECULAR-SIEVE CHROMATOGRAPHY.

Authors:  G K ACKERS
Journal:  Biochemistry       Date:  1964-05       Impact factor: 3.162

3.  Isoelectric points of proteins, determined by isoelectric focusing in the presence of urea and ethanol.

Authors:  W J Gelsema; C L de Ligny; N G van der Veen
Journal:  J Chromatogr       Date:  1979-04-01

4.  SC5b-9 complex of complement: formation of the dimeric membrane attack complex by removal of S-protein.

Authors:  E R Podack; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

Review 5.  The proteolytic activation systems of complement.

Authors:  K B Reid; R R Porter
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Improved methodology for the analysis of mixtures by band centrifugation. Quantitative determination of components in protein mixtures.

Authors:  T Kranz; K H Schmidt
Journal:  J Biol Stand       Date:  1981-01

7.  Heparin with two binding sites for antithrombin or platelet factor 4.

Authors:  R E Jordan; L V Favreau; E H Braswell; R D Rosenberg
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

8.  Large scale isolation of functionally active components of the human complement system.

Authors:  C H Hammer; G H Wirtz; L Renfer; H D Gresham; B F Tack
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

9.  Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.

Authors:  E R Podack; J Tschoop; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

10.  Membrane attack complex of complement: a structural analysis of its assembly.

Authors:  E R Podack; A F Esser; G Biesecker; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  31 in total

1.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes.

Authors:  Lawrence C Thompson; Sumit Goswami; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

3.  Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces. Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and -independent mechanisms.

Authors:  M Hermann; M E Jaconi; C Dahlgren; F A Waldvogel; O Stendahl; D P Lew
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 4.  Evidence for an extra-cellular function for protein kinase A.

Authors:  S Shaltiel; I Schvartz; B Korc-Grodzicki; T Kreizman
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

5.  Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice.

Authors:  N A Boyd; A R Bradwell; R A Thompson
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

6.  Knockout and knockin of the beta1 exon D define distinct roles for integrin splice variants in heart function and embryonic development.

Authors:  C Baudoin; M J Goumans; C Mummery; A Sonnenberg
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

7.  Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

Authors:  G S Chhatwal; K T Preissner; G Müller-Berghaus; H Blobel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

8.  Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 synthesis by diacylglycerol, phorbol ester, and thrombin.

Authors:  J Grulich-Henn; G Müller-Berghaus
Journal:  Blut       Date:  1990-07

9.  Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.

Authors:  S Bhakdi; R Käflein; T S Halstensen; F Hugo; K T Preissner; T E Mollnes
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

10.  Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells.

Authors:  A H Limper; J E Standing; O A Hoffman; M Castro; L W Neese
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.